GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » EV-to-EBIT

ENCell Co (XKRX:456070) EV-to-EBIT : -11.92 (As of May. 22, 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ENCell Co's Enterprise Value is ₩120,738 Mil. ENCell Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-10,131 Mil. Therefore, ENCell Co's EV-to-EBIT for today is -11.92.

The historical rank and industry rank for ENCell Co's EV-to-EBIT or its related term are showing as below:

XKRX:456070' s EV-to-EBIT Range Over the Past 10 Years
Min: -61.29   Med: -15.19   Max: -11.22
Current: -11.92

During the past 5 years, the highest EV-to-EBIT of ENCell Co was -11.22. The lowest was -61.29. And the median was -15.19.

XKRX:456070's EV-to-EBIT is ranked worse than
100% of 472 companies
in the Biotechnology industry
Industry Median: 8.34 vs XKRX:456070: -11.92

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. ENCell Co's Enterprise Value for the quarter that ended in Mar. 2025 was ₩153,936 Mil. ENCell Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-10,131 Mil. ENCell Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was -6.58%.


ENCell Co EV-to-EBIT Historical Data

The historical data trend for ENCell Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co EV-to-EBIT Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
- - - - -10.74

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -22.89 -10.74 -15.19

Competitive Comparison of ENCell Co's EV-to-EBIT

For the Biotechnology subindustry, ENCell Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENCell Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ENCell Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ENCell Co's EV-to-EBIT falls into.


;
;

ENCell Co EV-to-EBIT Calculation

ENCell Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=120737.832/-10131.156
=-11.92

ENCell Co's current Enterprise Value is ₩120,738 Mil.
ENCell Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-10,131 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENCell Co  (XKRX:456070) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

ENCell Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=-10131.156/153935.85
=-6.58 %

ENCell Co's Enterprise Value for the quarter that ended in Mar. 2025 was ₩153,936 Mil.
ENCell Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-10,131 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENCell Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of ENCell Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


ENCell Co Business Description

Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines